Sudarshan Pharma Industries Ltd (SPIL) has been granted 'One Star Export House' status by the Ministry of Commerce and ...

Targeting a corpus of INR 200 crore, with a greenshoe option of INR 100 crore, the fund aims to support early-stage biotech companies in India. The portfolio will comprise 20-25 B2B startups ...

Zumutor Biologics is among a new breed of biotech startups from India focused on immuno-oncology — treatment that boosts the immune system to fight cancer. What stands out about the company ...

The UCPMP was introduced in March last year with an objective to bring about transparency and ensure ethical conduct in the ...

to scout for new destinations such as India. Anthem says it works with several small and emerging biotech companies and a handful of big names such as Bayer. Like Aragen, it plans to ramp up the ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.

Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for ...

We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...

Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of ...